BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15276103)

  • 1. Effectiveness of sirolimus-eluting stent implantation for treatment of in-stent restenosis after brachytherapy failure.
    Iakovou I; Sangiorgi GM; Stankovic G; Corvaja N; Michev I; Chieffo A; Rogacka R; Vitrella G; Airoldi F; Colombo A
    Am J Cardiol; 2004 Aug; 94(3):351-4. PubMed ID: 15276103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous therapy of bifurcation lesions with drug-eluting stent implantation: the Culotte technique revisited.
    Hoye A; van Mieghem CA; Ong AT; Aoki J; Rodriguez Granillo GA; Valgimigli M; Tsuchida K; Sianos G; McFadden EP; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW
    Int J Cardiovasc Intervent; 2005; 7(1):36-40. PubMed ID: 16019613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial.
    Holmes DR; Teirstein PS; Satler L; Sketch MH; Popma JJ; Mauri L; Wang HP; Schleckser PA; Cohen SA;
    JACC Cardiovasc Interv; 2008 Aug; 1(4):439-48. PubMed ID: 19463342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome of patients undergoing low aggressive angioplasty combined with brachytherapy and short-term dual antiplatelet therapy for in-stent restenosis.
    Di Pede F; Buja P; Millosevich P; Grassi G; Celestre M; Zuin G; Marchetti C; Pizzi G; Antonello M; Bindoni L; Raviele A
    J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):731-6. PubMed ID: 17001233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus-eluting stents for the prevention of restenosis in a worst-case scenario of diffuse and recurrent in-stent restenosis.
    Werner GS; Emig U; Krack A; Schwarz G; Figulla HR
    Catheter Cardiovasc Interv; 2004 Nov; 63(3):259-64. PubMed ID: 15505841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial.
    Togni M; Eber S; Widmer J; Billinger M; Wenaweser P; Cook S; Vogel R; Seiler C; Eberli FR; Maier W; Corti R; Roffi M; Lüscher TF; Garachemani A; Hess OM; Wandel S; Meier B; Jüni P; Windecker S
    J Am Coll Cardiol; 2007 Sep; 50(12):1123-31. PubMed ID: 17868802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results and follow-up after implantation of four or more sirolimus-eluting stents in the same patient.
    Iakovou I; Sangiorgi GM; Stankovic G; Corvaja N; Vitrella G; Ferraro M; Colombo A
    Catheter Cardiovasc Interv; 2005 Apr; 64(4):436-9; discussion 440-1. PubMed ID: 15789401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medium-term results from the clinical and angiographic follow-up of patients after angioplasty and implantation of sirolimus-eluting stents.
    Dardas PS; Tsikaderis DD; Mezilis NE; Hatzimiltiadis S
    Hellenic J Cardiol; 2005; 46(2):117-23. PubMed ID: 15847131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial.
    Holmes DR; Teirstein P; Satler L; Sketch M; O'Malley J; Popma JJ; Kuntz RE; Fitzgerald PJ; Wang H; Caramanica E; Cohen SA;
    JAMA; 2006 Mar; 295(11):1264-73. PubMed ID: 16531619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeat intracoronary beta-brachytherapy using a rhenium-188-filled balloon catheter for recurrent restenosis in patients who failed intracoronary radiation therapy.
    Wöhrle J; Krause BJ; Nusser T; Kochs M; Höher M
    Cardiovasc Revasc Med; 2006; 7(1):2-6. PubMed ID: 16513516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late target lesion revascularization after implantation of sirolimus-eluting stent.
    Hong MK; Mintz GS; Lee CW; Park DW; Lee SW; Kim YH; Jung IH; Kim SH; Cheong SS; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):299-303. PubMed ID: 17985380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes.
    Lemos PA; van Mieghem CA; Arampatzis CA; Hoye A; Ong AT; McFadden E; Sianos G; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW
    Circulation; 2004 Jun; 109(21):2500-2. PubMed ID: 15148279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial.
    Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Van den Branden F; Van Langenhove G;
    J Am Coll Cardiol; 2007 Jul; 50(3):261-7. PubMed ID: 17631219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries.
    Lee CW; Suh J; Lee SW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2007 May; 69(6):821-5. PubMed ID: 17191211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes after management of restenosis or thrombosis of drug-eluting stents.
    Mishkel GJ; Moore AL; Markwell S; Shelton MC; Shelton ME
    J Am Coll Cardiol; 2007 Jan; 49(2):181-4. PubMed ID: 17222728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between sirolimus-eluting stents and intracoronary catheter-based beta radiation for the treatment of in-stent restenosis.
    Feres F; Muñoz JS; Abizaid A; Albertal M; Mintz GS; Staico R; Centemero M; Mattos LA; Maldonado G; Tanajura LF; Chaves A; Pinto I; Abizaid AS; Seixas AC; Vaz VD; Sousa A; Sousa JE
    Am J Cardiol; 2005 Dec; 96(12):1656-62. PubMed ID: 16360353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superiority of sirolimus eluting stent compared with intracoronary beta radiation for treatment of in-stent restenosis: a matched comparison.
    Iofina E; Radke PW; Skurzewski P; Haager PK; Blindt R; Koch KC; Hanrath P; vom Dahl J; Hoffmann R
    Heart; 2005 Dec; 91(12):1584-9. PubMed ID: 15797938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SIRIUS-DIRECT trial: a multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesions.
    Moses JW; Weisz G; Mishkel G; Caputo R; O'shaughnessey C; Wong SC; Fischell TA; Mooney M; Williams DO; Popma JJ; Fitzgerald P; Smith S; Kuntz RE; Collins M; Cohen SA; Leon MB
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):505-12. PubMed ID: 17896408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.
    Kastrati A; Mehilli J; von Beckerath N; Dibra A; Hausleiter J; Pache J; Schühlen H; Schmitt C; Dirschinger J; Schömig A;
    JAMA; 2005 Jan; 293(2):165-71. PubMed ID: 15644543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-eluting stent implantation in bifurcated lesions with balloon-crushing technique and 6 fr guiding catheter: immediate and mid-term results.
    Lozano I; Avanzas P; Lee DH; Lasa G; Rondán J; Moris C
    J Invasive Cardiol; 2007 Jan; 19(1):27-31. PubMed ID: 17297182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.